Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Resistance Intervention after Stroke Trial
2008-005546-23Phase 3Active
- Sponsor
- Yale University
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in insulin resistance (IR), ischemic stroke, transient ischaemic attack (TIA) and 1 more comparing Pioglitazone with Placebo (2 arms). Primary endpoint: Primary composite cardiovascular endpoint. Started May 2009; status: active.
02
Drugs
pioglitazone
03
Conditions
insulin resistance (IR)ischemic stroketransient ischaemic attack (TIA)myocardial infarction (MI)
Beyond the preview
Go deeper on 2008-005546-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005546-23.